Skip to main content
. 2020 Oct 26;9(11):2358. doi: 10.3390/cells9112358

Figure 1.

Figure 1

Comparison of the molecular subclassification systems applied to triple-negative breast cancers (TNBCs) by the PAM50 assay (Prosigna) and by Lehmann et al. [8]. The basal-like (BL) 1, BL2, immune-modulatory (IM) and mesenchymal (M) subclasses are preferentially of the PAM50 basal-like intrinsic subtype. UNC = unspecified.